nodes	percent_of_prediction	percent_of_DWPC	metapath
Salicylate-sodium—PTGS2—prostate cancer	0.417	1	CbGaD
Salicylate-sodium—PTGS2—Etoposide—prostate cancer	0.0444	0.542	CbGbCtD
Salicylate-sodium—PTGS1—Etoposide—prostate cancer	0.0375	0.458	CbGbCtD
Salicylate-sodium—Acetylsalicylic acid—TP53—prostate cancer	0.00145	0.325	CrCbGaD
Salicylate-sodium—Mesalazine—MPO—prostate cancer	0.000882	0.197	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—CYP2C19—prostate cancer	0.000457	0.102	CrCbGaD
Salicylate-sodium—Magnesium salicylate—PTGS2—prostate cancer	0.000448	0.1	CrCbGaD
Salicylate-sodium—Salsalate—PTGS2—prostate cancer	0.000381	0.0852	CrCbGaD
Salicylate-sodium—Mesalazine—PTGS2—prostate cancer	0.00033	0.0739	CrCbGaD
Salicylate-sodium—Acetylsalicylic acid—PTGS2—prostate cancer	0.000284	0.0636	CrCbGaD
Salicylate-sodium—Salicylic acid—PTGS2—prostate cancer	0.000234	0.0524	CrCbGaD
Salicylate-sodium—Vision blurred—Capecitabine—prostate cancer	0.000114	0.000312	CcSEcCtD
Salicylate-sodium—Asthenia—Estradiol—prostate cancer	0.000113	0.000311	CcSEcCtD
Salicylate-sodium—Abdominal distension—Doxorubicin—prostate cancer	0.000113	0.000309	CcSEcCtD
Salicylate-sodium—Syncope—Docetaxel—prostate cancer	0.000112	0.000307	CcSEcCtD
Salicylate-sodium—Pruritus—Estradiol—prostate cancer	0.000112	0.000307	CcSEcCtD
Salicylate-sodium—Asthma—Doxorubicin—prostate cancer	0.000112	0.000307	CcSEcCtD
Salicylate-sodium—Dysphagia—Doxorubicin—prostate cancer	0.000112	0.000307	CcSEcCtD
Salicylate-sodium—Arrhythmia—Prednisone—prostate cancer	0.00011	0.000303	CcSEcCtD
Salicylate-sodium—Palpitations—Docetaxel—prostate cancer	0.00011	0.000302	CcSEcCtD
Salicylate-sodium—Paraesthesia—Etoposide—prostate cancer	0.00011	0.000302	CcSEcCtD
Salicylate-sodium—Weight increased—Epirubicin—prostate cancer	0.00011	0.000302	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Docetaxel—prostate cancer	0.00011	0.000301	CcSEcCtD
Salicylate-sodium—Dyspnoea—Etoposide—prostate cancer	0.000109	0.0003	CcSEcCtD
Salicylate-sodium—Somnolence—Etoposide—prostate cancer	0.000109	0.000299	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Mitoxantrone—prostate cancer	0.000109	0.000298	CcSEcCtD
Salicylate-sodium—Syncope—Capecitabine—prostate cancer	0.000108	0.000297	CcSEcCtD
Salicylate-sodium—Diarrhoea—Estradiol—prostate cancer	0.000108	0.000297	CcSEcCtD
Salicylate-sodium—Convulsion—Docetaxel—prostate cancer	0.000108	0.000297	CcSEcCtD
Salicylate-sodium—Drowsiness—Epirubicin—prostate cancer	0.000108	0.000295	CcSEcCtD
Salicylate-sodium—Erythema—Prednisone—prostate cancer	0.000108	0.000295	CcSEcCtD
Salicylate-sodium—Bronchitis—Doxorubicin—prostate cancer	0.000108	0.000295	CcSEcCtD
Salicylate-sodium—Palpitations—Capecitabine—prostate cancer	0.000107	0.000293	CcSEcCtD
Salicylate-sodium—Decreased appetite—Etoposide—prostate cancer	0.000107	0.000292	CcSEcCtD
Salicylate-sodium—Chest pain—Docetaxel—prostate cancer	0.000106	0.000291	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Capecitabine—prostate cancer	0.000106	0.000291	CcSEcCtD
Salicylate-sodium—Renal failure—Epirubicin—prostate cancer	0.000106	0.00029	CcSEcCtD
Salicylate-sodium—Asthenia—Mitoxantrone—prostate cancer	0.000106	0.00029	CcSEcCtD
Salicylate-sodium—Fatigue—Etoposide—prostate cancer	0.000106	0.00029	CcSEcCtD
Salicylate-sodium—Constipation—Etoposide—prostate cancer	0.000105	0.000287	CcSEcCtD
Salicylate-sodium—Pain—Etoposide—prostate cancer	0.000105	0.000287	CcSEcCtD
Salicylate-sodium—Dizziness—Estradiol—prostate cancer	0.000105	0.000287	CcSEcCtD
Salicylate-sodium—Chest pain—Capecitabine—prostate cancer	0.000103	0.000282	CcSEcCtD
Salicylate-sodium—Confusional state—Docetaxel—prostate cancer	0.000103	0.000282	CcSEcCtD
Salicylate-sodium—Anxiety—Capecitabine—prostate cancer	0.000103	0.000281	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Docetaxel—prostate cancer	0.000102	0.000279	CcSEcCtD
Salicylate-sodium—Oedema—Docetaxel—prostate cancer	0.000102	0.000279	CcSEcCtD
Salicylate-sodium—Weight increased—Doxorubicin—prostate cancer	0.000102	0.000279	CcSEcCtD
Salicylate-sodium—Epistaxis—Epirubicin—prostate cancer	0.000102	0.000279	CcSEcCtD
Salicylate-sodium—Vision blurred—Prednisone—prostate cancer	0.000101	0.000278	CcSEcCtD
Salicylate-sodium—Infection—Docetaxel—prostate cancer	0.000101	0.000278	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Etoposide—prostate cancer	0.000101	0.000277	CcSEcCtD
Salicylate-sodium—Diarrhoea—Mitoxantrone—prostate cancer	0.000101	0.000276	CcSEcCtD
Salicylate-sodium—Vomiting—Estradiol—prostate cancer	0.000101	0.000276	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Etoposide—prostate cancer	0.0001	0.000275	CcSEcCtD
Salicylate-sodium—Shock—Docetaxel—prostate cancer	0.0001	0.000275	CcSEcCtD
Salicylate-sodium—Rash—Estradiol—prostate cancer	9.97e-05	0.000273	CcSEcCtD
Salicylate-sodium—Drowsiness—Doxorubicin—prostate cancer	9.97e-05	0.000273	CcSEcCtD
Salicylate-sodium—Dermatitis—Estradiol—prostate cancer	9.96e-05	0.000273	CcSEcCtD
Salicylate-sodium—Confusional state—Capecitabine—prostate cancer	9.95e-05	0.000273	CcSEcCtD
Salicylate-sodium—Tachycardia—Docetaxel—prostate cancer	9.94e-05	0.000273	CcSEcCtD
Salicylate-sodium—Headache—Estradiol—prostate cancer	9.91e-05	0.000272	CcSEcCtD
Salicylate-sodium—Oedema—Capecitabine—prostate cancer	9.86e-05	0.00027	CcSEcCtD
Salicylate-sodium—Renal failure—Doxorubicin—prostate cancer	9.8e-05	0.000269	CcSEcCtD
Salicylate-sodium—Infection—Capecitabine—prostate cancer	9.8e-05	0.000269	CcSEcCtD
Salicylate-sodium—Urticaria—Etoposide—prostate cancer	9.74e-05	0.000267	CcSEcCtD
Salicylate-sodium—Anorexia—Docetaxel—prostate cancer	9.71e-05	0.000266	CcSEcCtD
Salicylate-sodium—Shock—Capecitabine—prostate cancer	9.7e-05	0.000266	CcSEcCtD
Salicylate-sodium—Body temperature increased—Etoposide—prostate cancer	9.69e-05	0.000266	CcSEcCtD
Salicylate-sodium—Abdominal pain—Etoposide—prostate cancer	9.69e-05	0.000266	CcSEcCtD
Salicylate-sodium—Hepatitis—Epirubicin—prostate cancer	9.67e-05	0.000265	CcSEcCtD
Salicylate-sodium—Syncope—Prednisone—prostate cancer	9.65e-05	0.000265	CcSEcCtD
Salicylate-sodium—Tachycardia—Capecitabine—prostate cancer	9.63e-05	0.000264	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Epirubicin—prostate cancer	9.62e-05	0.000264	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Capecitabine—prostate cancer	9.54e-05	0.000261	CcSEcCtD
Salicylate-sodium—Hypotension—Docetaxel—prostate cancer	9.52e-05	0.000261	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Prednisone—prostate cancer	9.46e-05	0.000259	CcSEcCtD
Salicylate-sodium—Epistaxis—Doxorubicin—prostate cancer	9.4e-05	0.000258	CcSEcCtD
Salicylate-sodium—Anorexia—Capecitabine—prostate cancer	9.4e-05	0.000258	CcSEcCtD
Salicylate-sodium—Nausea—Estradiol—prostate cancer	9.4e-05	0.000258	CcSEcCtD
Salicylate-sodium—Vomiting—Mitoxantrone—prostate cancer	9.37e-05	0.000257	CcSEcCtD
Salicylate-sodium—Convulsion—Prednisone—prostate cancer	9.33e-05	0.000256	CcSEcCtD
Salicylate-sodium—Rash—Mitoxantrone—prostate cancer	9.29e-05	0.000255	CcSEcCtD
Salicylate-sodium—Dermatitis—Mitoxantrone—prostate cancer	9.28e-05	0.000255	CcSEcCtD
Salicylate-sodium—Headache—Mitoxantrone—prostate cancer	9.23e-05	0.000253	CcSEcCtD
Salicylate-sodium—Hypotension—Capecitabine—prostate cancer	9.22e-05	0.000253	CcSEcCtD
Salicylate-sodium—Paraesthesia—Docetaxel—prostate cancer	9.15e-05	0.000251	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Epirubicin—prostate cancer	9.15e-05	0.000251	CcSEcCtD
Salicylate-sodium—Anxiety—Prednisone—prostate cancer	9.13e-05	0.00025	CcSEcCtD
Salicylate-sodium—Dyspnoea—Docetaxel—prostate cancer	9.08e-05	0.000249	CcSEcCtD
Salicylate-sodium—Somnolence—Docetaxel—prostate cancer	9.06e-05	0.000248	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Etoposide—prostate cancer	9.03e-05	0.000248	CcSEcCtD
Salicylate-sodium—Tinnitus—Epirubicin—prostate cancer	9.02e-05	0.000247	CcSEcCtD
Salicylate-sodium—Dyspepsia—Docetaxel—prostate cancer	8.97e-05	0.000246	CcSEcCtD
Salicylate-sodium—Hepatitis—Doxorubicin—prostate cancer	8.95e-05	0.000245	CcSEcCtD
Salicylate-sodium—Hypoaesthesia—Doxorubicin—prostate cancer	8.9e-05	0.000244	CcSEcCtD
Salicylate-sodium—Paraesthesia—Capecitabine—prostate cancer	8.86e-05	0.000243	CcSEcCtD
Salicylate-sodium—Decreased appetite—Docetaxel—prostate cancer	8.86e-05	0.000243	CcSEcCtD
Salicylate-sodium—Asthenia—Etoposide—prostate cancer	8.8e-05	0.000241	CcSEcCtD
Salicylate-sodium—Dyspnoea—Capecitabine—prostate cancer	8.79e-05	0.000241	CcSEcCtD
Salicylate-sodium—Oedema—Prednisone—prostate cancer	8.79e-05	0.000241	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Prednisone—prostate cancer	8.79e-05	0.000241	CcSEcCtD
Salicylate-sodium—Fatigue—Docetaxel—prostate cancer	8.78e-05	0.000241	CcSEcCtD
Salicylate-sodium—Nausea—Mitoxantrone—prostate cancer	8.75e-05	0.00024	CcSEcCtD
Salicylate-sodium—Infection—Prednisone—prostate cancer	8.73e-05	0.000239	CcSEcCtD
Salicylate-sodium—Pain—Docetaxel—prostate cancer	8.71e-05	0.000239	CcSEcCtD
Salicylate-sodium—Constipation—Docetaxel—prostate cancer	8.71e-05	0.000239	CcSEcCtD
Salicylate-sodium—Dyspepsia—Capecitabine—prostate cancer	8.68e-05	0.000238	CcSEcCtD
Salicylate-sodium—Pruritus—Etoposide—prostate cancer	8.67e-05	0.000238	CcSEcCtD
Salicylate-sodium—Shock—Prednisone—prostate cancer	8.64e-05	0.000237	CcSEcCtD
Salicylate-sodium—Arrhythmia—Epirubicin—prostate cancer	8.64e-05	0.000237	CcSEcCtD
Salicylate-sodium—Tachycardia—Prednisone—prostate cancer	8.58e-05	0.000235	CcSEcCtD
Salicylate-sodium—Decreased appetite—Capecitabine—prostate cancer	8.57e-05	0.000235	CcSEcCtD
Salicylate-sodium—Fatigue—Capecitabine—prostate cancer	8.5e-05	0.000233	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Prednisone—prostate cancer	8.49e-05	0.000233	CcSEcCtD
Salicylate-sodium—Erythema multiforme—Doxorubicin—prostate cancer	8.46e-05	0.000232	CcSEcCtD
Salicylate-sodium—Constipation—Capecitabine—prostate cancer	8.44e-05	0.000231	CcSEcCtD
Salicylate-sodium—Pain—Capecitabine—prostate cancer	8.44e-05	0.000231	CcSEcCtD
Salicylate-sodium—Erythema—Epirubicin—prostate cancer	8.42e-05	0.000231	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Docetaxel—prostate cancer	8.4e-05	0.00023	CcSEcCtD
Salicylate-sodium—Diarrhoea—Etoposide—prostate cancer	8.39e-05	0.00023	CcSEcCtD
Salicylate-sodium—Anorexia—Prednisone—prostate cancer	8.38e-05	0.00023	CcSEcCtD
Salicylate-sodium—Tinnitus—Doxorubicin—prostate cancer	8.34e-05	0.000229	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Docetaxel—prostate cancer	8.33e-05	0.000228	CcSEcCtD
Salicylate-sodium—Flatulence—Epirubicin—prostate cancer	8.3e-05	0.000227	CcSEcCtD
Salicylate-sodium—Dysgeusia—Epirubicin—prostate cancer	8.25e-05	0.000226	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Capecitabine—prostate cancer	8.13e-05	0.000223	CcSEcCtD
Salicylate-sodium—Dizziness—Etoposide—prostate cancer	8.11e-05	0.000222	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Capecitabine—prostate cancer	8.07e-05	0.000221	CcSEcCtD
Salicylate-sodium—Body temperature increased—Docetaxel—prostate cancer	8.05e-05	0.000221	CcSEcCtD
Salicylate-sodium—Abdominal pain—Docetaxel—prostate cancer	8.05e-05	0.000221	CcSEcCtD
Salicylate-sodium—Arrhythmia—Doxorubicin—prostate cancer	8e-05	0.000219	CcSEcCtD
Salicylate-sodium—Vision blurred—Epirubicin—prostate cancer	7.94e-05	0.000218	CcSEcCtD
Salicylate-sodium—Paraesthesia—Prednisone—prostate cancer	7.89e-05	0.000216	CcSEcCtD
Salicylate-sodium—Urticaria—Capecitabine—prostate cancer	7.84e-05	0.000215	CcSEcCtD
Salicylate-sodium—Abdominal pain—Capecitabine—prostate cancer	7.8e-05	0.000214	CcSEcCtD
Salicylate-sodium—Body temperature increased—Capecitabine—prostate cancer	7.8e-05	0.000214	CcSEcCtD
Salicylate-sodium—Vomiting—Etoposide—prostate cancer	7.79e-05	0.000214	CcSEcCtD
Salicylate-sodium—Erythema—Doxorubicin—prostate cancer	7.79e-05	0.000214	CcSEcCtD
Salicylate-sodium—Dyspepsia—Prednisone—prostate cancer	7.73e-05	0.000212	CcSEcCtD
Salicylate-sodium—Rash—Etoposide—prostate cancer	7.73e-05	0.000212	CcSEcCtD
Salicylate-sodium—Dermatitis—Etoposide—prostate cancer	7.72e-05	0.000212	CcSEcCtD
Salicylate-sodium—Headache—Etoposide—prostate cancer	7.68e-05	0.000211	CcSEcCtD
Salicylate-sodium—Flatulence—Doxorubicin—prostate cancer	7.68e-05	0.00021	CcSEcCtD
Salicylate-sodium—Decreased appetite—Prednisone—prostate cancer	7.64e-05	0.000209	CcSEcCtD
Salicylate-sodium—Dysgeusia—Doxorubicin—prostate cancer	7.63e-05	0.000209	CcSEcCtD
Salicylate-sodium—Fatigue—Prednisone—prostate cancer	7.58e-05	0.000208	CcSEcCtD
Salicylate-sodium—Syncope—Epirubicin—prostate cancer	7.55e-05	0.000207	CcSEcCtD
Salicylate-sodium—Constipation—Prednisone—prostate cancer	7.51e-05	0.000206	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Docetaxel—prostate cancer	7.51e-05	0.000206	CcSEcCtD
Salicylate-sodium—Palpitations—Epirubicin—prostate cancer	7.44e-05	0.000204	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Epirubicin—prostate cancer	7.4e-05	0.000203	CcSEcCtD
Salicylate-sodium—Vision blurred—Doxorubicin—prostate cancer	7.34e-05	0.000201	CcSEcCtD
Salicylate-sodium—Asthenia—Docetaxel—prostate cancer	7.31e-05	0.0002	CcSEcCtD
Salicylate-sodium—Convulsion—Epirubicin—prostate cancer	7.3e-05	0.0002	CcSEcCtD
Salicylate-sodium—Nausea—Etoposide—prostate cancer	7.28e-05	0.0002	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Capecitabine—prostate cancer	7.27e-05	0.000199	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Prednisone—prostate cancer	7.24e-05	0.000199	CcSEcCtD
Salicylate-sodium—Pruritus—Docetaxel—prostate cancer	7.21e-05	0.000198	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Prednisone—prostate cancer	7.18e-05	0.000197	CcSEcCtD
Salicylate-sodium—Chest pain—Epirubicin—prostate cancer	7.17e-05	0.000197	CcSEcCtD
Salicylate-sodium—Anxiety—Epirubicin—prostate cancer	7.14e-05	0.000196	CcSEcCtD
Salicylate-sodium—Asthenia—Capecitabine—prostate cancer	7.08e-05	0.000194	CcSEcCtD
Salicylate-sodium—Syncope—Doxorubicin—prostate cancer	6.99e-05	0.000192	CcSEcCtD
Salicylate-sodium—Urticaria—Prednisone—prostate cancer	6.98e-05	0.000191	CcSEcCtD
Salicylate-sodium—Pruritus—Capecitabine—prostate cancer	6.98e-05	0.000191	CcSEcCtD
Salicylate-sodium—Diarrhoea—Docetaxel—prostate cancer	6.97e-05	0.000191	CcSEcCtD
Salicylate-sodium—Body temperature increased—Prednisone—prostate cancer	6.95e-05	0.00019	CcSEcCtD
Salicylate-sodium—Abdominal pain—Prednisone—prostate cancer	6.95e-05	0.00019	CcSEcCtD
Salicylate-sodium—Confusional state—Epirubicin—prostate cancer	6.93e-05	0.00019	CcSEcCtD
Salicylate-sodium—Palpitations—Doxorubicin—prostate cancer	6.88e-05	0.000189	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Epirubicin—prostate cancer	6.87e-05	0.000188	CcSEcCtD
Salicylate-sodium—Oedema—Epirubicin—prostate cancer	6.87e-05	0.000188	CcSEcCtD
Salicylate-sodium—Loss of consciousness—Doxorubicin—prostate cancer	6.85e-05	0.000188	CcSEcCtD
Salicylate-sodium—Infection—Epirubicin—prostate cancer	6.83e-05	0.000187	CcSEcCtD
Salicylate-sodium—Shock—Epirubicin—prostate cancer	6.76e-05	0.000185	CcSEcCtD
Salicylate-sodium—Convulsion—Doxorubicin—prostate cancer	6.75e-05	0.000185	CcSEcCtD
Salicylate-sodium—Diarrhoea—Capecitabine—prostate cancer	6.75e-05	0.000185	CcSEcCtD
Salicylate-sodium—Dizziness—Docetaxel—prostate cancer	6.74e-05	0.000185	CcSEcCtD
Salicylate-sodium—Tachycardia—Epirubicin—prostate cancer	6.71e-05	0.000184	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Epirubicin—prostate cancer	6.64e-05	0.000182	CcSEcCtD
Salicylate-sodium—Chest pain—Doxorubicin—prostate cancer	6.63e-05	0.000182	CcSEcCtD
Salicylate-sodium—Anxiety—Doxorubicin—prostate cancer	6.61e-05	0.000181	CcSEcCtD
Salicylate-sodium—Anorexia—Epirubicin—prostate cancer	6.55e-05	0.00018	CcSEcCtD
Salicylate-sodium—Dizziness—Capecitabine—prostate cancer	6.52e-05	0.000179	CcSEcCtD
Salicylate-sodium—Vomiting—Docetaxel—prostate cancer	6.48e-05	0.000178	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Prednisone—prostate cancer	6.47e-05	0.000177	CcSEcCtD
Salicylate-sodium—Rash—Docetaxel—prostate cancer	6.42e-05	0.000176	CcSEcCtD
Salicylate-sodium—Hypotension—Epirubicin—prostate cancer	6.42e-05	0.000176	CcSEcCtD
Salicylate-sodium—Dermatitis—Docetaxel—prostate cancer	6.42e-05	0.000176	CcSEcCtD
Salicylate-sodium—Confusional state—Doxorubicin—prostate cancer	6.41e-05	0.000176	CcSEcCtD
Salicylate-sodium—Headache—Docetaxel—prostate cancer	6.38e-05	0.000175	CcSEcCtD
Salicylate-sodium—Anaphylactic shock—Doxorubicin—prostate cancer	6.36e-05	0.000174	CcSEcCtD
Salicylate-sodium—Oedema—Doxorubicin—prostate cancer	6.36e-05	0.000174	CcSEcCtD
Salicylate-sodium—Infection—Doxorubicin—prostate cancer	6.32e-05	0.000173	CcSEcCtD
Salicylate-sodium—Asthenia—Prednisone—prostate cancer	6.3e-05	0.000173	CcSEcCtD
Salicylate-sodium—Vomiting—Capecitabine—prostate cancer	6.27e-05	0.000172	CcSEcCtD
Salicylate-sodium—Shock—Doxorubicin—prostate cancer	6.26e-05	0.000172	CcSEcCtD
Salicylate-sodium—Rash—Capecitabine—prostate cancer	6.22e-05	0.000171	CcSEcCtD
Salicylate-sodium—Pruritus—Prednisone—prostate cancer	6.22e-05	0.00017	CcSEcCtD
Salicylate-sodium—Dermatitis—Capecitabine—prostate cancer	6.21e-05	0.00017	CcSEcCtD
Salicylate-sodium—Tachycardia—Doxorubicin—prostate cancer	6.21e-05	0.00017	CcSEcCtD
Salicylate-sodium—Headache—Capecitabine—prostate cancer	6.18e-05	0.000169	CcSEcCtD
Salicylate-sodium—Paraesthesia—Epirubicin—prostate cancer	6.17e-05	0.000169	CcSEcCtD
Salicylate-sodium—Hyperhidrosis—Doxorubicin—prostate cancer	6.15e-05	0.000169	CcSEcCtD
Salicylate-sodium—Dyspnoea—Epirubicin—prostate cancer	6.13e-05	0.000168	CcSEcCtD
Salicylate-sodium—Somnolence—Epirubicin—prostate cancer	6.11e-05	0.000168	CcSEcCtD
Salicylate-sodium—Anorexia—Doxorubicin—prostate cancer	6.06e-05	0.000166	CcSEcCtD
Salicylate-sodium—Nausea—Docetaxel—prostate cancer	6.05e-05	0.000166	CcSEcCtD
Salicylate-sodium—Dyspepsia—Epirubicin—prostate cancer	6.05e-05	0.000166	CcSEcCtD
Salicylate-sodium—Diarrhoea—Prednisone—prostate cancer	6.01e-05	0.000165	CcSEcCtD
Salicylate-sodium—Decreased appetite—Epirubicin—prostate cancer	5.97e-05	0.000164	CcSEcCtD
Salicylate-sodium—Hypotension—Doxorubicin—prostate cancer	5.94e-05	0.000163	CcSEcCtD
Salicylate-sodium—Fatigue—Epirubicin—prostate cancer	5.92e-05	0.000162	CcSEcCtD
Salicylate-sodium—Pain—Epirubicin—prostate cancer	5.88e-05	0.000161	CcSEcCtD
Salicylate-sodium—Constipation—Epirubicin—prostate cancer	5.88e-05	0.000161	CcSEcCtD
Salicylate-sodium—Nausea—Capecitabine—prostate cancer	5.86e-05	0.000161	CcSEcCtD
Salicylate-sodium—Dizziness—Prednisone—prostate cancer	5.81e-05	0.000159	CcSEcCtD
Salicylate-sodium—Paraesthesia—Doxorubicin—prostate cancer	5.71e-05	0.000157	CcSEcCtD
Salicylate-sodium—Dyspnoea—Doxorubicin—prostate cancer	5.67e-05	0.000155	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Epirubicin—prostate cancer	5.66e-05	0.000155	CcSEcCtD
Salicylate-sodium—Somnolence—Doxorubicin—prostate cancer	5.65e-05	0.000155	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Epirubicin—prostate cancer	5.62e-05	0.000154	CcSEcCtD
Salicylate-sodium—Dyspepsia—Doxorubicin—prostate cancer	5.6e-05	0.000153	CcSEcCtD
Salicylate-sodium—Vomiting—Prednisone—prostate cancer	5.59e-05	0.000153	CcSEcCtD
Salicylate-sodium—Rash—Prednisone—prostate cancer	5.54e-05	0.000152	CcSEcCtD
Salicylate-sodium—Dermatitis—Prednisone—prostate cancer	5.53e-05	0.000152	CcSEcCtD
Salicylate-sodium—Decreased appetite—Doxorubicin—prostate cancer	5.53e-05	0.000152	CcSEcCtD
Salicylate-sodium—Headache—Prednisone—prostate cancer	5.5e-05	0.000151	CcSEcCtD
Salicylate-sodium—Fatigue—Doxorubicin—prostate cancer	5.48e-05	0.00015	CcSEcCtD
Salicylate-sodium—Urticaria—Epirubicin—prostate cancer	5.46e-05	0.00015	CcSEcCtD
Salicylate-sodium—Pain—Doxorubicin—prostate cancer	5.44e-05	0.000149	CcSEcCtD
Salicylate-sodium—Constipation—Doxorubicin—prostate cancer	5.44e-05	0.000149	CcSEcCtD
Salicylate-sodium—Body temperature increased—Epirubicin—prostate cancer	5.43e-05	0.000149	CcSEcCtD
Salicylate-sodium—Abdominal pain—Epirubicin—prostate cancer	5.43e-05	0.000149	CcSEcCtD
Salicylate-sodium—Feeling abnormal—Doxorubicin—prostate cancer	5.24e-05	0.000144	CcSEcCtD
Salicylate-sodium—Nausea—Prednisone—prostate cancer	5.22e-05	0.000143	CcSEcCtD
Salicylate-sodium—Gastrointestinal pain—Doxorubicin—prostate cancer	5.2e-05	0.000143	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Epirubicin—prostate cancer	5.06e-05	0.000139	CcSEcCtD
Salicylate-sodium—Urticaria—Doxorubicin—prostate cancer	5.05e-05	0.000138	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—LDHB—prostate cancer	5.05e-05	0.000382	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPL12—prostate cancer	5.05e-05	0.000382	CbGpPWpGaD
Salicylate-sodium—Abdominal pain—Doxorubicin—prostate cancer	5.03e-05	0.000138	CcSEcCtD
Salicylate-sodium—Body temperature increased—Doxorubicin—prostate cancer	5.03e-05	0.000138	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—TNFRSF21—prostate cancer	4.97e-05	0.000376	CbGpPWpGaD
Salicylate-sodium—Asthenia—Epirubicin—prostate cancer	4.93e-05	0.000135	CcSEcCtD
Salicylate-sodium—Pruritus—Epirubicin—prostate cancer	4.86e-05	0.000133	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—CYP7B1—prostate cancer	4.84e-05	0.000366	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTAP—prostate cancer	4.84e-05	0.000366	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—prostate cancer	4.83e-05	0.000365	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HSD3B1—prostate cancer	4.82e-05	0.000364	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC22A3—prostate cancer	4.82e-05	0.000364	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TCN2—prostate cancer	4.78e-05	0.000362	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—prostate cancer	4.74e-05	0.000358	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	4.73e-05	0.000357	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SULT1E1—prostate cancer	4.71e-05	0.000356	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SRD5A1—prostate cancer	4.71e-05	0.000356	CbGpPWpGaD
Salicylate-sodium—Diarrhoea—Epirubicin—prostate cancer	4.7e-05	0.000129	CcSEcCtD
Salicylate-sodium—Hypersensitivity—Doxorubicin—prostate cancer	4.68e-05	0.000128	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—LPL—prostate cancer	4.67e-05	0.000353	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTA4—prostate cancer	4.62e-05	0.000349	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TBXAS1—prostate cancer	4.62e-05	0.000349	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—prostate cancer	4.61e-05	0.000349	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	4.58e-05	0.000346	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—prostate cancer	4.56e-05	0.000345	CbGpPWpGaD
Salicylate-sodium—Asthenia—Doxorubicin—prostate cancer	4.56e-05	0.000125	CcSEcCtD
Salicylate-sodium—Dizziness—Epirubicin—prostate cancer	4.54e-05	0.000125	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	4.51e-05	0.000341	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	4.51e-05	0.000341	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTA2—prostate cancer	4.5e-05	0.00034	CbGpPWpGaD
Salicylate-sodium—Pruritus—Doxorubicin—prostate cancer	4.5e-05	0.000123	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—HSD17B3—prostate cancer	4.5e-05	0.00034	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ACSL4—prostate cancer	4.5e-05	0.00034	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—TP53—prostate cancer	4.46e-05	0.000338	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—prostate cancer	4.46e-05	0.000337	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—prostate cancer	4.45e-05	0.000336	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ABCG5—prostate cancer	4.44e-05	0.000336	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SULT1A1—prostate cancer	4.44e-05	0.000336	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	4.44e-05	0.000336	CbGpPWpGaD
Salicylate-sodium—Vomiting—Epirubicin—prostate cancer	4.37e-05	0.00012	CcSEcCtD
Salicylate-sodium—Diarrhoea—Doxorubicin—prostate cancer	4.35e-05	0.000119	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—GSTA1—prostate cancer	4.34e-05	0.000328	CbGpPWpGaD
Salicylate-sodium—Rash—Epirubicin—prostate cancer	4.33e-05	0.000119	CcSEcCtD
Salicylate-sodium—Dermatitis—Epirubicin—prostate cancer	4.33e-05	0.000119	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—UMPS—prostate cancer	4.31e-05	0.000326	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ARG2—prostate cancer	4.31e-05	0.000326	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PHGDH—prostate cancer	4.31e-05	0.000326	CbGpPWpGaD
Salicylate-sodium—Headache—Epirubicin—prostate cancer	4.3e-05	0.000118	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—HSD3B2—prostate cancer	4.29e-05	0.000325	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTO1—prostate cancer	4.29e-05	0.000325	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NAT2—prostate cancer	4.29e-05	0.000325	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	4.29e-05	0.000324	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EP300—prostate cancer	4.24e-05	0.000321	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LDHB—prostate cancer	4.23e-05	0.00032	CbGpPWpGaD
Salicylate-sodium—Dizziness—Doxorubicin—prostate cancer	4.2e-05	0.000115	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—CYP3A5—prostate cancer	4.15e-05	0.000314	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	4.13e-05	0.000312	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—prostate cancer	4.13e-05	0.000312	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PLCB2—prostate cancer	4.11e-05	0.000311	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LRP2—prostate cancer	4.11e-05	0.000311	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2C18—prostate cancer	4.11e-05	0.000311	CbGpPWpGaD
Salicylate-sodium—PTGS2—Spinal Cord Injury—IL6—prostate cancer	4.09e-05	0.000309	CbGpPWpGaD
Salicylate-sodium—Nausea—Epirubicin—prostate cancer	4.08e-05	0.000112	CcSEcCtD
Salicylate-sodium—PTGS2—Disease—GSTO1—prostate cancer	4.07e-05	0.000308	CbGpPWpGaD
Salicylate-sodium—Vomiting—Doxorubicin—prostate cancer	4.04e-05	0.000111	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—P4HB—prostate cancer	4.04e-05	0.000305	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—prostate cancer	4.02e-05	0.000304	CbGpPWpGaD
Salicylate-sodium—Rash—Doxorubicin—prostate cancer	4.01e-05	0.00011	CcSEcCtD
Salicylate-sodium—PTGS2—Metabolism—PDHA1—prostate cancer	4.01e-05	0.000303	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TCN2—prostate cancer	4.01e-05	0.000303	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA3—prostate cancer	4.01e-05	0.000303	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—UCP3—prostate cancer	4.01e-05	0.000303	CbGpPWpGaD
Salicylate-sodium—Dermatitis—Doxorubicin—prostate cancer	4.01e-05	0.00011	CcSEcCtD
Salicylate-sodium—Headache—Doxorubicin—prostate cancer	3.98e-05	0.000109	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—SLC22A1—prostate cancer	3.93e-05	0.000297	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LRP2—prostate cancer	3.9e-05	0.000295	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.88e-05	0.000293	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SULT2A1—prostate cancer	3.83e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EIF2AK2—prostate cancer	3.83e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPL10—prostate cancer	3.83e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—P4HB—prostate cancer	3.83e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HSD3B1—prostate cancer	3.82e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC22A3—prostate cancer	3.82e-05	0.000289	CbGpPWpGaD
Salicylate-sodium—Nausea—Doxorubicin—prostate cancer	3.78e-05	0.000104	CcSEcCtD
Salicylate-sodium—PTGS1—Metabolism—MED12—prostate cancer	3.76e-05	0.000285	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HIST1H2BG—prostate cancer	3.75e-05	0.000284	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GNG5—prostate cancer	3.73e-05	0.000282	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	3.71e-05	0.000281	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—prostate cancer	3.7e-05	0.00028	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—prostate cancer	3.69e-05	0.000279	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TBXAS1—prostate cancer	3.66e-05	0.000277	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA4—prostate cancer	3.66e-05	0.000277	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HIST1H4H—prostate cancer	3.63e-05	0.000274	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NPPA—prostate cancer	3.63e-05	0.000274	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—prostate cancer	3.62e-05	0.000273	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NCOA3—prostate cancer	3.6e-05	0.000272	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	3.58e-05	0.000271	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA2—prostate cancer	3.57e-05	0.00027	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	3.53e-05	0.000267	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SULT1A1—prostate cancer	3.53e-05	0.000267	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ABCG5—prostate cancer	3.53e-05	0.000267	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTA1—prostate cancer	3.45e-05	0.000261	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—HPGDS—prostate cancer	3.43e-05	0.00026	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—prostate cancer	3.42e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2C19—prostate cancer	3.41e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTO1—prostate cancer	3.41e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NAT2—prostate cancer	3.41e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HSD3B2—prostate cancer	3.41e-05	0.000258	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTT1—prostate cancer	3.33e-05	0.000252	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ACHE—prostate cancer	3.33e-05	0.000252	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2A6—prostate cancer	3.29e-05	0.000249	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	3.28e-05	0.000248	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	3.28e-05	0.000248	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PLCB2—prostate cancer	3.27e-05	0.000247	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2C18—prostate cancer	3.27e-05	0.000247	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LRP2—prostate cancer	3.27e-05	0.000247	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—P4HB—prostate cancer	3.2e-05	0.000242	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKR1C3—prostate cancer	3.2e-05	0.000242	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PRKACB—prostate cancer	3.18e-05	0.000241	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP17A1—prostate cancer	3.15e-05	0.000238	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—prostate cancer	3.14e-05	0.000237	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC22A1—prostate cancer	3.12e-05	0.000236	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	3.11e-05	0.000235	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFBR1—prostate cancer	3.08e-05	0.000233	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—B2M—prostate cancer	3.08e-05	0.000233	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	3.08e-05	0.000233	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SULT2A1—prostate cancer	3.04e-05	0.00023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—prostate cancer	3.04e-05	0.00023	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—RPS19—prostate cancer	3.03e-05	0.000229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKR1C3—prostate cancer	3.03e-05	0.000229	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRKACB—prostate cancer	3.02e-05	0.000228	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NCOA2—prostate cancer	3e-05	0.000227	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MED12—prostate cancer	2.99e-05	0.000226	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GNG5—prostate cancer	2.96e-05	0.000224	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PPP3CA—prostate cancer	2.94e-05	0.000222	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—SLC5A5—prostate cancer	2.86e-05	0.000217	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NCOA3—prostate cancer	2.86e-05	0.000216	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRKCZ—prostate cancer	2.85e-05	0.000215	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	2.81e-05	0.000212	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP2E1—prostate cancer	2.8e-05	0.000212	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CALR—prostate cancer	2.8e-05	0.000211	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NQO1—prostate cancer	2.77e-05	0.000209	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PARP1—prostate cancer	2.75e-05	0.000208	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGFR4—prostate cancer	2.75e-05	0.000208	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TH—prostate cancer	2.73e-05	0.000206	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—HPGDS—prostate cancer	2.72e-05	0.000206	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CALCA—prostate cancer	2.71e-05	0.000205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.71e-05	0.000205	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2C19—prostate cancer	2.71e-05	0.000205	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP3A4—prostate cancer	2.7e-05	0.000204	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	2.68e-05	0.000203	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1B1—prostate cancer	2.65e-05	0.000201	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTT1—prostate cancer	2.64e-05	0.0002	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ACHE—prostate cancer	2.64e-05	0.0002	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2A6—prostate cancer	2.61e-05	0.000198	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HSPA1A—prostate cancer	2.6e-05	0.000197	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	2.6e-05	0.000197	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GGT1—prostate cancer	2.57e-05	0.000194	CbGpPWpGaD
Salicylate-sodium—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—prostate cancer	2.56e-05	0.000194	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKR1C3—prostate cancer	2.54e-05	0.000192	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NCOA1—prostate cancer	2.53e-05	0.000191	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PRKACB—prostate cancer	2.53e-05	0.000191	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP17A1—prostate cancer	2.5e-05	0.000189	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CASP9—prostate cancer	2.5e-05	0.000189	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP19A1—prostate cancer	2.49e-05	0.000189	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	2.47e-05	0.000187	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PRKCQ—prostate cancer	2.42e-05	0.000183	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—RXRA—prostate cancer	2.41e-05	0.000182	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NCOA2—prostate cancer	2.38e-05	0.00018	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	2.34e-05	0.000177	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—COMT—prostate cancer	2.32e-05	0.000175	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTP1—prostate cancer	2.31e-05	0.000174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF10—prostate cancer	2.3e-05	0.000174	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—SLC5A5—prostate cancer	2.27e-05	0.000172	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ITPR1—prostate cancer	2.27e-05	0.000172	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—EP300—prostate cancer	2.23e-05	0.000169	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP2E1—prostate cancer	2.22e-05	0.000168	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NQO1—prostate cancer	2.2e-05	0.000166	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFBR2—prostate cancer	2.19e-05	0.000165	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TH—prostate cancer	2.16e-05	0.000164	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ITPR1—prostate cancer	2.15e-05	0.000163	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	2.15e-05	0.000163	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—TYMS—prostate cancer	2.14e-05	0.000162	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP3A4—prostate cancer	2.14e-05	0.000162	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—GSTM1—prostate cancer	2.12e-05	0.00016	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1B1—prostate cancer	2.1e-05	0.000159	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—LPL—prostate cancer	2.08e-05	0.000157	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GGT1—prostate cancer	2.04e-05	0.000154	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CYP1A1—prostate cancer	2.01e-05	0.000152	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NCOA1—prostate cancer	2.01e-05	0.000152	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—ERCC2—prostate cancer	1.99e-05	0.000151	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP19A1—prostate cancer	1.98e-05	0.00015	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—LPL—prostate cancer	1.97e-05	0.000149	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PDGFRB—prostate cancer	1.95e-05	0.000148	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—RXRA—prostate cancer	1.91e-05	0.000144	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERCC2—prostate cancer	1.89e-05	0.000143	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—MTHFR—prostate cancer	1.87e-05	0.000142	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	1.86e-05	0.000141	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB3—prostate cancer	1.85e-05	0.00014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGFR2—prostate cancer	1.84e-05	0.00014	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—COMT—prostate cancer	1.84e-05	0.000139	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PPARA—prostate cancer	1.84e-05	0.000139	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTP1—prostate cancer	1.83e-05	0.000138	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ITPR1—prostate cancer	1.8e-05	0.000136	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MTHFR—prostate cancer	1.78e-05	0.000134	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	1.77e-05	0.000134	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TERT—prostate cancer	1.77e-05	0.000134	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CAV1—prostate cancer	1.73e-05	0.000131	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—TYMS—prostate cancer	1.7e-05	0.000129	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—HIF1A—prostate cancer	1.69e-05	0.000128	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—GSTM1—prostate cancer	1.68e-05	0.000127	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—LPL—prostate cancer	1.65e-05	0.000125	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.65e-05	0.000125	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CAV1—prostate cancer	1.64e-05	0.000124	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CYP1A1—prostate cancer	1.6e-05	0.000121	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—ERCC2—prostate cancer	1.58e-05	0.00012	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CG—prostate cancer	1.57e-05	0.000119	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—BAD—prostate cancer	1.54e-05	0.000117	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—APC—prostate cancer	1.49e-05	0.000113	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—INS—prostate cancer	1.49e-05	0.000113	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—MTHFR—prostate cancer	1.49e-05	0.000112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IRS1—prostate cancer	1.47e-05	0.000112	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGF—prostate cancer	1.47e-05	0.000112	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—CREBBP—prostate cancer	1.46e-05	0.00011	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PPARA—prostate cancer	1.46e-05	0.00011	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—GSK3B—prostate cancer	1.43e-05	0.000108	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—INS—prostate cancer	1.41e-05	0.000107	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CD—prostate cancer	1.38e-05	0.000105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CREBBP—prostate cancer	1.38e-05	0.000105	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CAV1—prostate cancer	1.37e-05	0.000104	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MAP2K1—prostate cancer	1.32e-05	9.99e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CD—prostate cancer	1.31e-05	9.92e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	1.31e-05	9.91e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—NOS3—prostate cancer	1.31e-05	9.88e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SERPINE1—prostate cancer	1.3e-05	9.81e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—FGF2—prostate cancer	1.26e-05	9.5e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CG—prostate cancer	1.25e-05	9.45e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—NOS3—prostate cancer	1.24e-05	9.37e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CB—prostate cancer	1.21e-05	9.12e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—JAK2—prostate cancer	1.2e-05	9.1e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTGS2—prostate cancer	1.2e-05	9.04e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—INS—prostate cancer	1.18e-05	8.95e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MDM2—prostate cancer	1.18e-05	8.89e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—CREBBP—prostate cancer	1.16e-05	8.76e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—ERBB2—prostate cancer	1.16e-05	8.76e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CB—prostate cancer	1.14e-05	8.65e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CD—prostate cancer	1.1e-05	8.31e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1B—prostate cancer	1.07e-05	8.11e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PTEN—prostate cancer	1.04e-05	7.88e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—NOS3—prostate cancer	1.04e-05	7.84e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CTNNB1—prostate cancer	1.01e-05	7.67e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—EP300—prostate cancer	9.94e-06	7.52e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—CDKN1A—prostate cancer	9.9e-06	7.49e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PTEN—prostate cancer	9.88e-06	7.47e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CB—prostate cancer	9.57e-06	7.24e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EP300—prostate cancer	9.42e-06	7.13e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—SRC—prostate cancer	9.16e-06	6.93e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—STAT3—prostate cancer	8.84e-06	6.68e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PTEN—prostate cancer	8.27e-06	6.26e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—MYC—prostate cancer	8.21e-06	6.21e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—TGFB1—prostate cancer	8.19e-06	6.19e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—EGFR—prostate cancer	8.03e-06	6.07e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—EP300—prostate cancer	7.89e-06	5.97e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—KRAS—prostate cancer	7.59e-06	5.74e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—PIK3CA—prostate cancer	7.35e-06	5.56e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—PIK3CA—prostate cancer	6.97e-06	5.27e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—IL6—prostate cancer	6.17e-06	4.67e-05	CbGpPWpGaD
Salicylate-sodium—PTGS1—Metabolism—AKT1—prostate cancer	6.01e-06	4.54e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—PIK3CA—prostate cancer	5.84e-06	4.41e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Disease—AKT1—prostate cancer	5.69e-06	4.31e-05	CbGpPWpGaD
Salicylate-sodium—PTGS2—Metabolism—AKT1—prostate cancer	4.77e-06	3.61e-05	CbGpPWpGaD
